STOCK TITAN

Calvert US Select Equity ETF (CVSE) Stock Price, News & Analysis

CVSE NYSE
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
3 251 sessions, October 14, 2024 to October 14, 2025
Largest daily move
+9.5% close of April 9, 2025
1-year change
+6.4% closing prices, October 14, 2024 to October 14, 2025

Company Description

Calvert US Select Equity ETF (ticker symbol CVSE) is an exchange-traded fund that is a series of Morgan Stanley ETF Trust. According to Morgan Stanley Investment Management, Inc., a Plan of Liquidation for the Fund has been approved by the Board of the Trust. Under this plan, the assets of the Fund are scheduled to be liquidated, its known or reasonably ascertainable liabilities will be satisfied or provided for, and the remaining proceeds will be distributed to shareholders. Following these steps, all issued and outstanding shares of the Fund will be redeemed as part of the liquidation process.

The Fund’s shares have traded on NYSE Arca, Inc. and, as described in the liquidation announcement, the Fund is expected to have a final full day of trading on NYSE Arca before trading in its shares is halted. After trading is halted, shareholders will not be able to sell shares on NYSE Arca and there may be no market for the purchase or sale of the Fund’s shares. Shareholders who remain invested through the liquidation date are expected to receive a liquidating distribution based on the proceeds from the Fund’s assets after liabilities are addressed.

Prior to the liquidation date, the Fund is expected to engage in activities focused on winding up its business and affairs. This includes transitioning its portfolio holdings to cash and cash equivalents in preparation for the orderly liquidation and subsequent distribution of proceeds to remaining shareholders. During this transition period, the Fund may no longer be pursuing its stated investment objective or be managed in line with its previously described investment strategies, which may affect its performance.

Shareholders, as described in the liquidation notice, have the option to sell their shares on NYSE Arca up to the final trading day, or to remain invested and receive the liquidating distribution. Authorized participants may continue to submit orders for the redemption of Creation Units in the manner described in the Fund’s prospectus until the liquidation process reaches the relevant cutoff. The announcement notes that shareholders who remain invested may bear increased brokerage and other transaction expenses related to the sale of portfolio investments prior to the liquidation date, and that the amount received in the liquidating distribution may be greater or less than the amount that could be obtained by selling shares on the exchange before trading is halted.

The liquidation announcement also highlights that, unless Fund shares are held in a tax-deferred account, the sale or liquidation of shares will generally be treated as a taxable event for shareholders. Investors are encouraged in that notice to consult a personal tax adviser regarding their particular tax situation, including the treatment of shares held in tax-deferred accounts such as individual retirement accounts, 401(k) plans, or 403(b) accounts and the tax consequences of selling shares or reinvesting proceeds from the liquidating distribution.

Calvert US Select Equity ETF is associated with Morgan Stanley Investment Management, Inc., which is described in the same announcement as part of a broader investment management business that serves a diverse client base. The Fund itself, however, is in the process of being wound down pursuant to the approved Plan of Liquidation. As a result, CVSE is best understood in the context of its liquidation and the related steps outlined for shareholders, trading on NYSE Arca, and the treatment of Fund assets and liabilities.

  • Fund structure: CVSE is a series of Morgan Stanley ETF Trust, operating as an exchange-traded fund with shares listed for trading on NYSE Arca prior to the halt associated with liquidation.
  • Plan of Liquidation: The Board of Morgan Stanley ETF Trust has approved a Plan of Liquidation for the Fund, under which its assets will be liquidated, liabilities will be addressed, and remaining proceeds distributed to shareholders, followed by the redemption of all outstanding shares.
  • Trading status: The liquidation announcement explains that the Fund is expected to have a last full day of trading on NYSE Arca, after which trading in its shares is anticipated to be halted and a market for the Fund’s shares may no longer exist.
  • Transition of assets: Before the liquidation date, the Fund is expected to transition its holdings into cash and cash equivalents in preparation for distributing proceeds to shareholders.
  • Tax considerations: The announcement notes that, in general, the sale or liquidation of shares is a taxable event unless shares are held in tax-deferred accounts, and it suggests that shareholders consult tax advisers.

Understanding CVSE in the context of its liquidation

For investors and researchers reviewing CVSE, the most relevant information is the Fund’s status under the Plan of Liquidation. The Fund’s business activities are described as being focused on winding up its affairs and preparing for the distribution of proceeds to shareholders. During this period, the Fund may not be managed according to its prior investment objective or strategies, which is noted as likely to affect performance.

The announcement also explains that shareholders who remain invested until the liquidation date will receive a liquidating distribution, while those who sell before the final trading day on NYSE Arca may realize a different outcome depending on market pricing and transaction costs. The notice emphasizes that there can be no assurance of a market for the Fund’s shares after trading is halted, which is an important structural consideration for those analyzing the ticker CVSE.

FAQs about Calvert US Select Equity ETF (CVSE)

  • What is Calvert US Select Equity ETF (CVSE)?
    Calvert US Select Equity ETF (CVSE) is an exchange-traded fund that is a series of Morgan Stanley ETF Trust. It has had its shares listed for trading on NYSE Arca, Inc., and is associated with Morgan Stanley Investment Management, Inc.
  • What is happening to CVSE?
    According to an announcement from Morgan Stanley Investment Management, Inc., the Board of Morgan Stanley ETF Trust has approved a Plan of Liquidation for Calvert US Select Equity ETF. Under this plan, the Fund’s assets will be liquidated, its liabilities will be satisfied or provided for, and remaining proceeds will be distributed to shareholders, after which all outstanding shares will be redeemed.
  • Will CVSE continue to trade on NYSE Arca?
    The liquidation announcement states that the Fund is expected to have a last full day of trading on NYSE Arca. After that point, trading in the Fund’s shares is expected to be halted, and shareholders will not be able to sell shares on NYSE Arca. There can be no assurance that a market for the purchase or sale of the Fund’s shares will exist after trading is halted.
  • What choices do shareholders of CVSE have before liquidation?
    The notice explains that shareholders may sell their shares on NYSE Arca up to the final trading day, potentially incurring typical transaction fees from their broker-dealer, or they may remain invested in the Fund and receive a liquidating distribution on the liquidation date. Authorized participants may also submit orders for the redemption of Creation Units in the manner described in the Fund’s prospectus until the relevant cutoff.
  • How might the liquidation affect CVSE’s investment objective and performance?
    Before the liquidation date, the Fund is described as engaging in activities to wind up its business and transition its assets to cash and cash equivalents. During this period, the Fund may no longer be pursuing its stated investment objective or following its prior investment strategies, and this is noted as likely to impact the Fund’s performance.
  • What tax considerations are mentioned for CVSE shareholders?
    The liquidation announcement notes that, unless Fund shares are held in a tax-deferred account, the sale or liquidation of shares will generally be considered a taxable event. It suggests that shareholders consult a personal tax adviser regarding their particular tax situation, including for shares held in tax-deferred accounts such as individual retirement accounts, 401(k) plans, or 403(b) accounts.
  • Who is associated with managing and distributing CVSE?
    The announcement identifies Morgan Stanley Investment Management, Inc. as the investment manager associated with the Fund and notes that the Fund is distributed by Foreside Fund Services, LLC.
  • Is CVSE considered an active fund or a fund in wind-down?
    Based on the Plan of Liquidation approved by the Board of Morgan Stanley ETF Trust, CVSE is described as engaging in business activities for the purpose of winding up its affairs and preparing for liquidation. This indicates that the Fund is in a wind-down phase rather than operating under its prior ongoing investment mandate.

Stock Performance

$—
-
-
Last updated:
+6.4%
Performance 1 year

Calvert US Select Equity ETF (CVSE) closed at $73.94 on October 14, 2025. Over the past 12 months, the price has gained 6.4%.

See what a $1,000 investment in CVSE would be worth today

CVSE Metrics & Rankings

Price returns through October 14, 2025. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

Calvert US Select Equity ETF has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. View all CVSE news →

SEC Filings

No SEC filings available for CVSE.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

Frequently Asked Questions

What is the current quoted price of Calvert US Select Equity ETF (CVSE)?

The current quoted price of Calvert US Select Equity ETF (CVSE) is $73.9449 as of October 14, 2025.